Ricardo Alves Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ricardo Alves Oliveira has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- A.F.B.P. Pinto
Universidade Federal do Vale do São Francisco, Brazil
1 shared publication - Artur Virgílio Simpson Martins
Instituto Federal de Rondônia - IFRO
1 shared publication B.D.M. Bastos
Universidade Federal do Vale do São Francisco, Brazil
1 shared publicationCláudia Do Ó Pessoa
Department of Physiology and Pharmacology , Federal University of Ceará , Rua Cel. Nunes de Melo, 1127, 60.430-270, Fortaleza, Brazil
1 shared publication- Daniel Maia Nogueira
Embrapa Semiárido, Brasil
1 shared publication - Edilson Soares Lopes Júnior
Laboratory of Physiology and Biotechnology of Animal Reproduction (LAFIBRA), Federal University of Vale do São Francisco, 56300-000, Campus of Agricultural Sciences, Petrolina-PE, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by Editora Poisson
O capital social em uma instituição educacional no município de Porto Velho – Rondônia – Brasil
- 1 January 2021
- Published by Editora Poisson
Open AccessO capital social em uma instituição educacional no município de Porto Velho – Rondônia – Brasil
- Open Access
- 1 April 2020
- Published by International Journal for Innovation Education and Research in International Journal for Innovation Education and Research
- Vol. 8 (4) , 237-244
Acceptance and Use of a Virtual Learning Environment (VLE): Structural Equations Modeling of the Unified Theory of Acceptance and Use of Technology
- 1 April 2020
- Published by International Journal for Innovation Education and Research in International Journal for Innovation Education and Research
- Vol. 8 (4) , 237-244
Open AccessAcceptance and Use of a Virtual Learning Environment (VLE): Structural Equations Modeling of the Unified Theory of Acceptance and Use of Technology
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 72 (1) , 25-32
Efeito da somatotropina bovina recombinante (rbST) na produção in vivo e na maturação in vitro de oócitos bovinos da raça Sindi
RESUMO A fim de avaliar o efeito de diferentes doses da rbST sobre a dinâmica folicular, a produção e a maturação in vitro de oócitos, 20 vacas Sindi, divididas em três grupos, receberam um dispositivo de progesterona intravaginal, estradiol e PGF2α, além de 2mL de solução salina (grupo controle), 250 (grupo rbST 250) ou 500mg de rbST (grupo rbST 500). Cinco dias depois, realizou-se a ovum pick up, e os complexos cumulus-oócitos (CCOs) recuperados foram selecionados, classificados e maturados in vitro. Os dados de contagem foram comparados pelo procedimento glht (General Linear Hypothesis Test), e os dados em porcentagem foram submetidos ao qui-quadrado, no programa estatístico R, onde as diferenças foram consideradas significativas quando P0,05) entre os grupos quanto à quantidade de folículos e à taxa de maturação. Os grupos rbST 250 e rbST 500 foram significativamente superiores (P<0,05) ao grupo controle em relação ao número de folículos grandes (0,42±0,20 vs. 0). O grupo rbST 500 apresentou maior (P<0,05) porcentagem de oócitos viáveis (91,52%) do que os grupos controle (67,85%) e rbST 250 (53,33%). A rbST aumenta o número de folículos grandes, e 500mg de rbST aumentam a porcentagem de oócitos viáveis em vacas Sindi.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 72 (1) , 25-32
Open AccessEfeito da somatotropina bovina recombinante (rbST) na produção in vivo e na maturação in vitro de oócitos bovinos da raça Sindi
RESUMO A fim de avaliar o efeito de diferentes doses da rbST sobre a dinâmica folicular, a produção e a maturação in vitro de oócitos, 20 vacas Sindi, divididas em três grupos, receberam um dispositivo de progesterona intravaginal, estradiol e PGF2α, além de 2mL de solução salina (grupo controle), 250 (grupo rbST 250) ou 500mg de rbST (grupo rbST 500). Cinco dias depois, realizou-se a ovum pick up, e os complexos cumulus-oócitos (CCOs) recuperados foram selecionados, classificados e maturados in vitro. Os dados de contagem foram comparados pelo procedimento glht (General Linear Hypothesis Test), e os dados em porcentagem foram submetidos ao qui-quadrado, no programa estatístico R, onde as diferenças foram consideradas significativas quando P0,05) entre os grupos quanto à quantidade de folículos e à taxa de maturação. Os grupos rbST 250 e rbST 500 foram significativamente superiores (P<0,05) ao grupo controle em relação ao número de folículos grandes (0,42±0,20 vs. 0). O grupo rbST 500 apresentou maior (P<0,05) porcentagem de oócitos viáveis (91,52%) do que os grupos controle (67,85%) e rbST 250 (53,33%). A rbST aumenta o número de folículos grandes, e 500mg de rbST aumentam a porcentagem de oócitos viáveis em vacas Sindi.
- 14 January 2008
- Published by Taylor & Francis in Journal of Herbs, Spices & Medicinal Plants
- Vol. 13 (2) , 41-57
Neuroprotective Actions of Tannins fromMyracrodruon urundeuvaon 6-Hydroxydopamine-Induced Neuronal Cell Death
In the present work we studied the neuroprotective effect of a tannin-enriched fraction (TEF) on rat primary mesencephalic cells culture, before (preventive protocol) and after (curative protocol) exposure to the neurotoxin 6-hydroxydopamine (6-OHDA). TEF was isolated from the stem bark of Myracrodruoun urundeuva, a Brazilian medicinal plant, largely used as a female genital tract antiinflammatory. The results showed that TEF (0.1 to 100 μg/ml) significantly reversed 6-OHDA-induced toxicity on neuronal cells as measured by the MTT assay, which expresses the degree of cell viability and integrity, in both protocols. Although the reversion was only partial, it was observed even at the lowest TEF concentration, and MTT absorbance returned to values close to those of controls. TEF was also very effective when added to cells culture before and after the neurotoxin, and reversed completely the 6-OHDA-induced lipid peroxidation, indicated by the formation of thiobarbituric acid reactive substances (TBAR...
- 14 January 2008
- Published by Taylor & Francis in Journal of Herbs, Spices & Medicinal Plants
- Vol. 13 (2) , 41-57
Neuroprotective Actions of Tannins fromMyracrodruon urundeuvaon 6-Hydroxydopamine-Induced Neuronal Cell Death
In the present work we studied the neuroprotective effect of a tannin-enriched fraction (TEF) on rat primary mesencephalic cells culture, before (preventive protocol) and after (curative protocol) exposure to the neurotoxin 6-hydroxydopamine (6-OHDA). TEF was isolated from the stem bark of Myracrodruoun urundeuva, a Brazilian medicinal plant, largely used as a female genital tract antiinflammatory. The results showed that TEF (0.1 to 100 μg/ml) significantly reversed 6-OHDA-induced toxicity on neuronal cells as measured by the MTT assay, which expresses the degree of cell viability and integrity, in both protocols. Although the reversion was only partial, it was observed even at the lowest TEF concentration, and MTT absorbance returned to values close to those of controls. TEF was also very effective when added to cells culture before and after the neurotoxin, and reversed completely the 6-OHDA-induced lipid peroxidation, indicated by the formation of thiobarbituric acid reactive substances (TBAR...
- Open Access
- 16 November 2005
- Published by American Society of Hematology in Blood
- Vol. 106 (11) , 4016
Bone Marrow Effects of High Dose Folic Acid Therapy in Chronic Idiopathic Thrombocytopenic Purpura.
Chronic idiopathic thrombocytopenic purpura (CITP) is an autoimmune disorder characterized by the production of autoantibodies against specific platelet antigens and characterized by low platelet counts in peripheral blood over a period of at least 6 months. Corticosteroids have been generally used as first line therapy with serious side effects. Previously, we described the beneficial effect of high dose folic acid (HDFA), 5 to 20 mg PO daily), in the therapy of this disease. Presently, we report the treatment of two patients with severe thrombocytopenia with HDFA. A 46 year old splenectomized woman (P1) and a 32 year old non-splenectomized man (P2), who were moderately refractory to prednisone and prednisolone, had a previous history of undifferentiated connective tissue disease characterized by one episode of arthritis (P2 with a positive rheumatoid factor and morning stiffness). Both patients had normal serum folic acid and vitamin B12, and no signs of megaloblastic or dysplastic alterations were evidenced in bone marrow aspirates. Ham test was negative and CD55/CD59 values for both patients were equal to normal controls. Bone marrow biopsies were also performed prior to the treatment with folic acid (FA) to evidence a global decrease in bone marrow cellularity (30% in case 1 and 20% in case 2). Concomitant infections or other diseases were excluded. Prednisone was tapered slowly, and high dose folic acid administration was initiated at this time. P1 achieved complete remission (CR) in 5 months with slowly tapering of folic acid during one year, remaining with normal platelet counts after one more year with no treatment. P2 achieved sustained partial remission (PR) with platelet counts ranging 63 x 109L to 113 x109/L. Interestingly, sequential bone marrow biopsies performed 2 years after the beginning of HDFA therapy revealed a marrow cellularity of 50% and 35% for P1 and P2, respectively. We demonstrated that the successful CR and PR to HDFA are associated with a significant increase in the overall bone marrow cellularity in both cases (20% in P1 and 15% in P2). Apoptotic features in idiopathic thrombocytopenic purpura (ITP) were characterized by Houwerzijl et al who demonstrated apoptosis and para-apoptosis as ultrastructural alterations in bone marrow megacaryocytes, supportive of ineffective thrombopoiesis as an underlying phenomenon in this study. Buemi et al demonstrated that addition of folic acid to the medium of vascular smooth muscle cells in culture inhibited the percentage of apoptotic and necrotic cells through a decrease in homocysteine concentration. The exact mechanism through which high dose folic acid is able to increase platelets measured in peripheral blood of patients with ITP and induce sustained CR and PR is so far unknown and remains to be explained. However, the present response to HDFA suggest a qualitative and especially quantitative role for this drug in protecting and upgrading the hematopoietic bone marrow and, consequently, restoring the platelet production in these 2 patients.
- 16 November 2005
- Published by American Society of Hematology in Blood
- Vol. 106 (11) , 4016
Open AccessBone Marrow Effects of High Dose Folic Acid Therapy in Chronic Idiopathic Thrombocytopenic Purpura.
Chronic idiopathic thrombocytopenic purpura (CITP) is an autoimmune disorder characterized by the production of autoantibodies against specific platelet antigens and characterized by low platelet counts in peripheral blood over a period of at least 6 months. Corticosteroids have been generally used as first line therapy with serious side effects. Previously, we described the beneficial effect of high dose folic acid (HDFA), 5 to 20 mg PO daily), in the therapy of this disease. Presently, we report the treatment of two patients with severe thrombocytopenia with HDFA. A 46 year old splenectomized woman (P1) and a 32 year old non-splenectomized man (P2), who were moderately refractory to prednisone and prednisolone, had a previous history of undifferentiated connective tissue disease characterized by one episode of arthritis (P2 with a positive rheumatoid factor and morning stiffness). Both patients had normal serum folic acid and vitamin B12, and no signs of megaloblastic or dysplastic alterations were evidenced in bone marrow aspirates. Ham test was negative and CD55/CD59 values for both patients were equal to normal controls. Bone marrow biopsies were also performed prior to the treatment with folic acid (FA) to evidence a global decrease in bone marrow cellularity (30% in case 1 and 20% in case 2). Concomitant infections or other diseases were excluded. Prednisone was tapered slowly, and high dose folic acid administration was initiated at this time. P1 achieved complete remission (CR) in 5 months with slowly tapering of folic acid during one year, remaining with normal platelet counts after one more year with no treatment. P2 achieved sustained partial remission (PR) with platelet counts ranging 63 x 109L to 113 x109/L. Interestingly, sequential bone marrow biopsies performed 2 years after the beginning of HDFA therapy revealed a marrow cellularity of 50% and 35% for P1 and P2, respectively. We demonstrated that the successful CR and PR to HDFA are associated with a significant increase in the overall bone marrow cellularity in both cases (20% in P1 and 15% in P2). Apoptotic features in idiopathic thrombocytopenic purpura (ITP) were characterized by Houwerzijl et al who demonstrated apoptosis and para-apoptosis as ultrastructural alterations in bone marrow megacaryocytes, supportive of ineffective thrombopoiesis as an underlying phenomenon in this study. Buemi et al demonstrated that addition of folic acid to the medium of vascular smooth muscle cells in culture inhibited the percentage of apoptotic and necrotic cells through a decrease in homocysteine concentration. The exact mechanism through which high dose folic acid is able to increase platelets measured in peripheral blood of patients with ITP and induce sustained CR and PR is so far unknown and remains to be explained. However, the present response to HDFA suggest a qualitative and especially quantitative role for this drug in protecting and upgrading the hematopoietic bone marrow and, consequently, restoring the platelet production in these 2 patients.